TY  - GEN
AU  - Yu,Yong
AU  - Qi,Jingjing
AU  - Xiong,Jieyi
AU  - Jiang,Liping
AU  - Cui,Di
AU  - He,Junlin
AU  - Chen,Ping
AU  - Li,Lianjie
AU  - Wu,Chenjie
AU  - Ma,Tonghui
AU  - Shao,Su
AU  - Wang,Jianjun
AU  - Yu,Dansong
AU  - Zhou,Bing
AU  - Huang,Dongsheng
AU  - Schmitt,Clemens A
AU  - Tao,Ran
TI  - Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer
SN  - 1838-7640
PY  - 2020///0114
KW  - Animals
KW  - Antibiotics, Antineoplastic
KW  - administration & dosage
KW  - Apoptosis
KW  - drug effects
KW  - Cancer Survivors
KW  - Cell Line, Tumor
KW  - Cellular Senescence
KW  - DNA Methylation
KW  - DNA, Neoplasm
KW  - metabolism
KW  - Doxorubicin
KW  - Drug Delivery Systems
KW  - Enhancer of Zeste Homolog 2 Protein
KW  - antagonists & inhibitors
KW  - Epigenesis, Genetic
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Indazoles
KW  - pharmacology
KW  - Mice
KW  - Mice, Nude
KW  - Mixed Function Oxygenases
KW  - Proto-Oncogene Proteins
KW  - Pyridones
KW  - Triple Negative Breast Neoplasms
KW  - genetics
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.7150/thno.29520
ER  -